Command Palette

Search for a command to run...

Clinical Trials · NCT01542242

Liraglutide Use in Prader-Willi Syndrome

TerminatedPhase 4Liraglutide (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Vancouver General Hospital
Enrollment
1
Start date
Feb 2012
Locations
1 site, Canada
Primary endpoint
Hemoglobin A1C
View Liraglutide compound reference